Virinchi Limited has approved the allotment of 74,00,000 (Seventy Four Lakh) convertible equity warrants on a preferential basis to Vivo Bio Tech Limited, a promoter group entity. The allotment was approved by the Stakeholders Relationship Committee at its meeting held on Friday, January 09, 2026.

Each warrant is priced at ₹28, consisting of a face value of ₹10 and a premium of ₹18. The company has received 25% of the issue price, amounting to ₹7 per warrant, totaling ₹5,18,00,000 (Rupees Five Crore Eighteen Lakh only). The remaining 75% of the issue price, ₹21 per warrant, is due upon conversion into fully paid-up equity shares. These warrants are convertible into an equal number of equity shares within 18 months from the date of allotment. If not exercised within this period, the warrants will lapse, and the amount paid will be forfeited.

This issuance follows a special resolution passed by shareholders at an Extra-Ordinary General Meeting on November 15, 2025, and received in-principle approval from BSE and NSE on December 31, 2025. Post allotment, the paid-up share capital of the company remains unchanged.